我的账户
亲爱的游客

欢迎您的光临

已有账号,请

如尚未注册?

第三方账号快捷登陆

试管婴儿

美国(HRC-Fertility)医院ENCINO (恩西诺):Robert Boostanfar(罗伯特·布斯坦福)

[复制链接]
美国试管婴儿 发表于 2016-1-10 17:34:13 | 显示全部楼层 |阅读模式 打印 上一主题 下一主题
  好国HRC死殖医疗中间:Robert Boostanfar(罗伯特·布斯坦祸大夫)
好国(HRC-Fertility)病院ENCINO (恩西诺):Robert Boostanfar(罗伯特·布斯坦祸)

【罗伯特大夫中文助理微旌旗灯号:1530863253】

  局认证

  死殖内排泄取没有孕症妇产科

  教术录用

  好国北减州年夜教的凯克医教院妇产科临床传授,

  任职阅历

  洛杉矶罗伯特旅游医疗中间

  普罗维登顺蟒扎纳医教中间

  西上平院

  好国HRC-Fertility死殖医疗中间

  得到奖项

  Vitals.com体恤大夫确以为2011年,2009年

  档羚安,好国,CNN,进修频讲“人物”纯志

  Vital.com的患者挑选奖,2010年

  Vital.com的患者挑选奖,2009年

  专业构造

  好国妇科背腔镜脚术协会会员

  好国妇产科医师教院

  好国死殖医教会会员

  范畴狄仔颈巴出书

  掌握性超排卵

  没有孕没有育症挑选性雌激素受体 调理剂

  挑选性雌激素受体 调理剂对子宫内膜癌战卵巢癌的影响

  帮助死殖手艺战扩大胚培育的仁攀类囊胚

  帮助死殖手艺战先辈妇女卵母细胞捐赠缓释促性腺激素医治

  生养年齿的促性腺激素开释激素拮抗剂正在掌握卵巢过分刺激的影响

【英文简介】


  Robert Boostanfar, M.D. F.A.C.O.G.

  PERSONAL INFORMATION

  Business Address HRC Fertility 1220 La Venta Avenue Suite 103 Westlake Village, CA. 91361

  15503 Ventura Blvd. Suite 200 Encino, CA. 91436 Business

 

  EDUCATION

  High School Crespi Carmelite High School Encino, California

  University University of California at Los Angeles Los Angeles, California B.S., Biological Sciences

  Medical School University of Southern California School of Medicine Los Angeles, California 90033

  Internship/Residency Los Angeles County + University of Southern California Medical Center Women’s and Children’s Hospital Department of Obstetrics and Gynecology Room L-1009 1240 North Mission Avenue Los Angeles, California 90033

  2

  Fellowship Los Angeles County + University of Southern California Medical Center Women’s and Children’s Hospital Department of Obstetrics and Gynecology Division of Reproductive Endocrinology & Infertility Room 8K9 1240 North Mission Avenue Los Angeles, California 90033

  Title Clinical Assistant Professor Department of Obstetrics and Gynecology Division Reproductive Endocrinology & Infertility University of Southern California Keck School of Medicine

  Board Certification Obstetrics and Gynecology Reproductive Endocrinology and Infertility

  Society Memberships

  American Association of Gynecological Laparoscopists

  American Society of Reproductive Medicine

  American College of Obstetrics and Gynecology

  Pacific Coast Reproductive Society

  Research Activities

  Major Areas of Research

  Extended Release Gonadotropin Therapy for Controlled Ovarian Hyperstimulation Selective Estrogen Receptor Modulator effects on Infertility Selective Estrogen Receptor Modulator effects on Endometrial and Ovarian Cancer Assisted Reproductive Technologies and extended embryo culture of Human Blastocysts Assisted Reproductive Technologies and Oocyte Donation in Menopausal Women Gonadotropin Releasing Hormone Antagonist effects during Controlled Ovarian Hyperstimulation

  3

  Publications

  Peer Review Journals

  1. Boostanfar R, Jain JK, Mishell DR, Paulson RJ. A prospective randomized trial comparing clomiphene citrate with tamoxifen citrate for ovulation induction. Fertility and Sterility. May 2001, Volume 75, No.5, pages 1024-1026.

  2. Boostanfar R, Jain JK, Slater CC, Tourgeman DE, Francis M, Paulson RJ. The prognostic significance of day 3 embryo cleavage stage on subsequent blastocyst development in a sequential culture system. Journal of Assisted Reproduction and Genetics. 2001, Vol. 18, No. 10, pages 548-550.

  3.Tourgeman DE, Boostanfar R, Chang L, Lu J, Stanczyk FZ, Paulson RJ. Is there evidence for preferential delivery of ovarian estradiol to the endometrium? Fertility and Sterility. June 2001, Volume 75, No. 6, Pages 1156-1158.

  4.Slater CC, Zhang C, Hodis HN, Mack WJ, Boostanfar R, Shoupe D, Paulson RJ, FZ Stanczyk. Comparison of Estrogen and Androgen Levels After Oral Estrogen WordStrment Therapy. The Journal of Reproductive Medicine. December 2001, Vol. 46, No. 12, pages 1052-1056.

  5. Paulson RJ, Boostanfar R, Saadat P, Mor E, Tourgeman D, Slater C, Francis M, Jain J. Pregnancy in the Sixth Decade of Life: Obstetric Outcomes in Women of Advanced Reproductive Age. JAMA November 2002, Vol. 288 No. 18 2320-2323.

  6. Boostanfar R, Amezcua C, Tourgeman DE, Roy S, Stanczyk FZ, Felix JC, Paulson RJ. The growth effects of raloxifene, estradiol, medroxyprogesterone acetate and progesterone on human endometrial adenocarcinoma cells. Fertility and Sterility January 2003, Volume 79, No. 1, Pages 223-225.

  7. Jain JK, Boostanfar R, Slater, CS, Francis MF, Paulson RJ. Monozygotic Twins and Triplets in Association with Blastocyst Transfer. Journal of Assisted Reproduction and Genetics, April 2004, Volume 21, No. 4, Pages 103-107.

  8. Saadat P, Boostanfar R, Slater CS, Tourgeman DE, Stanczyk FZ, Paulson RJ. Accelerated Endometrial Maturation In the Luteal Phase of Cycles Utilizing Controlled Ovarian Hyperstimulation: Impact of Gonadotropin-Releasing Hormone Agonists vs. Antagonists. Fertility and Sterility July 2004. Volume 82, No. 1, Pages 167-171.

  9. Wang H, Wen Y, Polan M, Boostanfar R, Feinman F, Behr B. Exogenous Granulocyte-Macrophage Colony Stimulating Factor Promotes Follicular Development In The Newborn Rat In Vivo. Human Reproduction, June 2005.

  10. Devroey P, Boostanfar R, Koper NP, Mannaerts BMJ, Ijzerman-Boon PC, Fauser BC. A Double Blind Non Inferiority RCT, Comparing Corifollitropin Alpha and

  4

  Recombinant FSH During the First Seven Days of Ovarian Stimulation Using a GnRH Antagonist Protocol. Human Reproduction Volume 24, No. 12, pp 3063-3072, 2009.

  Chapters

  1. Boostanfar R, Roy S: Genital Herpes. In: Management of Common Problems in Obstetrics and Gynecology. Fourth Edition. Mishell DR Jr, Goodwin TM, Brenner PF (eds.), Blackwell Science Publications, Boston, Massachusetts.

  2. Boostanfar R, Roy S: Wound Infections. In: Management of Common Problems in Obstetrics and Gynecology. Fourth Edition. Mishell DR Jr, Goodwin TM, Brenner PF (eds.), Blackwell Science Publications, Boston, Massachusetts.

  3. Boostanfar R, Roy S: Rectovaginal Injuries. In: Management of Common Problems in Obstetrics and Gynecology. Fourth Edition. Mishell DR Jr, Goodwin TM, Brenner PF (eds.), Blackwell Science Publications, Boston, Massachusetts. 4. Boostanfar R, Stanczyk F, Paulson RJ, Roy S: Diagnosis of Pregnancy. In: Management of Common Problems in Obstetrics and Gynecology. Fourth Edition. Mishell DR Jr, Goodwin TM, Brenner PF (eds.), Blackwell Science Publications, Boston, Massachusetts.

  5. Saadat P, Boostanfar R, Roy S: Postpartum Endometritis. In: Management of Common Problems in Obstetrics and Gynecology. Fourth Edition. Mishell DR Jr, Goodwin TM, Brenner PF (eds.), Blackwell Science Publications, Boston, Massachusetts.

  Scientific

  1. Kjos SL, Boostanfar R, Pezeshki K, Rafi I, Sanchez L, Bernstein GS, Kovacs A. Effects of medroxyprogesterone acetate on CD4 levels in HIV positive women. Presented at the Association of Reproductive Health Professionals, 1994. Washington D.C.

  2. Pezeshki K, Boostanfar R, Kjos SL. High estrogen dose oral contraceptives in women using anti-epileptic drugs may not protect against pregnancy. Presented at the Association of Reproductive Health Professionals, 1994. Washington D.C.

  3. Boostanfar R, Jain JK, Paulson RJ, Mishell DR Jr. A randomized trial comparing clomiphene citrate with tamoxifen for ovulation induction in obese anovulatory women. Presented at the 47th Annual Meeting of the Pacific Coast Reproductive Society, April 15-18, 1999, La Costa, California.

  4. Boostanfar R, Amezcua C, Tourgeman DE, Roy S, Stanczyk FZ, Felix J. The growth inhibitory effects of raloxifene on human endometrial adenocarcinoma ishikawa cells. Presented at the Society for Gynecologic Investigation, March 22-25, 2000, Chicago, Illinois.

  5

  5. Boostanfar R, Jain JK, Tourgeman DE, Slater CC, Francis MM, Paulson RJ. Blastocyst transfer is associated with an increased rate of monozygotic twins. Presented at the 48th Annual meeting of the Pacific Coast Reproductive Society, April 26-30, 2000, Rancho Mirage, California.

  6. Boostanfar R, Jain JK, Paulson RJ, Mishell Dr Jr. A prospective randomized trial comparing clomiphene citrate with tamoxifen citrate for ovulation induction. Presented at the 56th Annual Meeting of the American Society of Reproductive Medicine, October 2126, 2000, San Diego, California.

  7. Saadat P. Boostanfar R, Stanczyk FZ, Paulson RJ, Buckwalter G, Roy S. Effects of conjugated estrogens and medroxyprogesterone acetate or micronized progesterone on mood, libido and serum endocrine markers in postmenopausal women. Presented at the 56th Annual Meeting of the Obstetrical and Gynecological Assembly of Southern California, February 2, 2001, Los Angeles, California.

  8. Boostanfar R, Tourgeman, D, Amezcua C, Goharkay N, Roy S, Stanczyk FZ, Felix J. The comparative effects of raloxifene and progestins on endometrial adenocarcinoma cells in vitro. Presented at the 56th Annual Meeting of the Obstetrical and Gynecological Assembly of Southern California, February 2, 2001, Los Angeles, California.

  9. Tourgeman DE, Boostanfar R, Chang L, Lu J, Stanczyk FZ, Paulson RJ. Is there evidence for preferential delivery of ovarian estradiol to the endometrium? Presented at the 56th Annual Meeting of the Obstetrical and Gynecological Assembly of Southern California, February 2, 2001, Los Angeles, California.

  10. Boostanfar R, Melnik M, Amezcua C, Roy S, Stanczyk FZ, Felix J. The growth effects of raloxifene, medroxyprogeterone acetate and progesterone on human endometrial adenocarcinoma ishikawa cells. Presented at the Society for Gynecologic Investigation, March 21-24, 2001, Toronto, Canada.

  11. Boostanfar R, Jain JK, Tourgeman DE, Slater CC, Francis MM, Paulson RJ. High order multiple gestations as a result of monozygotic twinning associated with advanced embryo culture and blastocyst transfer. Presented at the Society for Gynecologic Investigation, March 21-24, 2001, Toronto, Canada.

  12. Saadat P. Boostanfar R, Stanczyk FZ, Paulson RJ, Buckwalter G, Roy S. Efffect of hormone replacement therapy containing medroxyprogesterone acetate or micronized progesterone on mood, libido and serum endocrine markers in postmenopausal women. Presented at the Society for Gynecologic Investigation, March 21-24, 2001, Toronto, Canada.

  13. Tourgeman DE, Lu JJ, Boostanfar R, Zheng W, Stanczyk FZ, Felix J, Paulson RJ. Gonadotropin modulation of ovarian neoplastic cell proliferation in vitro. . Presented at the 49th Annual meeting of the Pacific Coast Reproductive Society, April 25-29, 2001, Rancho Mirage, California.

  6

  14. Boostanfar R, Jain JK. Pregnancy outcome and clomiphene citrate dose. Presented at the 49th Annual meeting of the Pacific Coast Reproductive Society, April 25-29, 2001, Rancho Mirage, California.

  15. Boostanfar R, Sorenson L, Ambroggio J, Jain JK, Slater CC, Francis MM, Paulson RJ. Pregnancy outcome in women 50 or more years of age: A decade of experience. Presented at the 49th Annual meeting of the Pacific Coast Reproductive Society, April 2529, 2001, Rancho Mirage, California.

  16. Tourgeman DE, Amezcua, Boostanfar R, Stanczyk FZ, Felix J, Paulson RJ. Agonistic effects of raloxifene on ovarian adenocarcinoma (OVCAR-3) cells. Presented at The European Society of Human Reproduction and Embryology, July 1-4, 2001 Lausanne, Switzerland.

  17. Boostanfar R, Jain JK, Slater CC, Tourgeman DE, Francis M, Paulson RJ. The prognostic significance of day 3 embryo cleavage stage on subsequent blastocyst development in a sequential culture system. Presented at The European Society of Human Reproduction and Embryology, July 1-4, 2001 Lausanne, Switzerland.

  18. Boostanfar R, Campeau JD, Saadat P, Jain JK, Slater CC, Tourgeman DE, diZerega GS, Kobak WH. Use of the Harmonic Scalpel as a novel technique for distal neosalpingostomy. Presented at the American Association of Gynecologic Laparoscopists, November 16-19, 2001 San Francisco, Cailfornia.

  19. Boostanfar R, Saadat P, Poysky J, Stanczyk FZ, Buckwalter G, Roy S. Serum endocrine markers and psychosexual mood in postmenopausal women: is there a difference between transdermal and oral HRT? Presented at the 57th Annual Meeting of the American Society of Reproductive Medicine, October 20-25, 2001, Orlando, Florida.

  20. Saadat P, Boostanfar R, Poysky J, Stanczyk FZ, Buckwalter G, Roy S. Cognitive Function during hormone replacement therapy. Presented at the Society for Gynecologic Investigation, March 20-23, 2002, Los Angeles, California.

  21. Boostanfar R, Abbassi D, Tourgeman DE, Saadat P, Jain JK, Mishell DR, Paulson RJ. The comparative efficacy of Tamoxifen and Clomiphene Citrate in obese and nonobese women: A prospective randomized trial. Presented at the 50th Annual meeting of the Pacific Coast Reproductive Society, April 18-21, 2002, Rancho Mirage, California.

  22. Boostanfar R, Saadat P, Klumph S, Slater C, Jain JK, Paulson RJ. Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: Impact of GnRH agonists vs. antagonists. Presented at the 50th Annual meeting of the Pacific Coast Reproductive Society, April 18-21, 2002, Rancho Mirage, California.

  23. Saadat P, Boostanfar R, Mor E, Stanczyk FZ, Paulson RJ, Buckwalter G, Roy S. The effects of oral and transdermal hormone replacement therapy on serum free testosterone levels in postmenopausal women. Presented at the 50th Annual meeting of the Pacific Coast Reproductive Society, April 18-21, 2002, Rancho Mirage, California.

  7

  24. Saadat P, Boostanfar R, Poysky J, Stanczyk FZ, Buckwalter G, Roy S. A randomized prospective study comparing the effects of micronized progesterone and medroxyprogesterone acetate on mood and libido. Presented at the 50th Annual meeting of the Pacific Coast Reproductive Society, April 18-21, 2002, Rancho Mirage, California.

  25. Hsieh K, Boostanfar R, Slater CC. Distal Tubal Neosalpingostomy; A Retrospective Analysis of Laparoscopy vs. Laparotomy. Presented at University of Southern California Medical Research Symposium, April 24, 2002.

  26. Roy S, Boostanfar R, Saadat P, Poysky J, Stanczyk FZ, Buckwalter G. Serum Endocrine Markers and Pyscholsexual Mood in Postmenopausal Women: The Difference Between Transdermal and Oral HRT. Presented at the Berlin World Congress on the Menopause. June 13, 2002.

  27. Boostanfar R, Abbassi D, Tourgeman DE, Saadat P, Jain JK, Mishell DR, Paulson RJ. The comparative efficacy of Tamoxifen and Clomiphene Citrate in obese and nonobese women: A prospective randomized trial. Presented at the 50th Annual meeting of the Pacific Coast Reproductive Society, April 18-21, 2002, Rancho Mirage, California.

  28. Mor E, Boostanfar R, Saadat P, Tourgeman DE, Slater CC, Paulson RJ. Pregnancy outcome at the upper extreme of reproductive range: A comparison of two recipient groups. Presented at the 58th Annual Meeting of the American Society of Reproductive Medicine, October 12-17 2002, Seattle, Washington.

  29. Saadat P, Boostanfar R, Abbassi D, Tourgeman DE, Jain JK, Mishell DR, Paulson RJ. The effects of Tamoxifen and Clomiphene Citrate in obese and non-obese women: A randomized trial. Presented at the 71st Anniversary Pacific Coast Obstetrical and Gynecological Society, October 22-27, 2002, Rancho Mirage, California.

  30. Boostanfar R, Saadat P, Abbassi D, Tourgeman DE, Jain JK, Mishell DR, Paulson RJ. The effects of Tamoxifen and Clomiphene Citrate in obese and non-obese women: A randomized trial. Presented at the 58th Annual Meeting of the Obstetrical and Gynecological Assembly of Southern California, February 14, 2003, Los Angeles, California.

  31. Boostanfar R, Ivakhnenko V, Potter D, Feinman M, Behr B. Preimplantation genetic diagnosis after density gradient separation of the X and Y-bearing human spermatozoa. Presented at the 51st Annual meeting of the Pacific Coast Reproductive Society, April 2427, 2003, Rancho Mirage, California.

  32. Feinman M, Boostanfar R, Le A, Potter D, Khoury C, Behr B. Culturing cryopreserved cleavage stage embryos to blastocysts is a cost-effective method of utilizing frozen embryos. Presented at the 60th Annual Meeting of the American Society of Reproductive Medicine, October 16-20 2004, Philadelphia, PA.

  8

  33. Feinman M, Boostanfar R, A. Le, C. Gao. A comparison of down-regulation vs. antagonist protocols in ovum donor cycles... Presented at the 60th Annual Meeting of the American Society of Reproductive Medicine, October 16-20 2004, Philadelphia, PA.

  34.Wang H, Le A, Boostanfar R, Feinman M, Behr B. Regulation of CYP17 Expression in Theca-Interstitial Cells by GM-CSF. Presented at the 53rd Annual meeting of the Pacific Coast Reproductive Society, May 4-8, 2005, Indian Wells, California.

  35.Wang H, Le A, Boostanfar R, Feinman M, Behr B. The Clinical Outcomes of Cryopreserved Pronuclear Embryos from Standard IVF and ICSI. Presented at the 53rd Annual meeting of the Pacific Coast Reproductive Society, May 4-8, 2005, Indian Wells, California.

  36. Wang H, Le A, Boostanfar R, Feinman M, Behr B. Postthaw Embryo Compaction is Predictive of the Success of Frozen-Thawed Transfer. Presented at the 2005 Conjoint Annual Meeting of the American Society of Reproductive Medicine and the Canadian Fertility and Andrology Society, October 15-19 2005, Montreal, Quebec.

  37. Boostanfar R, Feinman M, Le A, Wang H, Behr B. Office Administration of Single Dose GnRH Antagonist: Minimizing Patient Injections Utilizing a Simple and Highly Effective IVF Protocol. Presented at the 2005 Conjoint Annual Meeting of the American Society of Reproductive Medicine and the Canadian Fertility and Andrology Society, October 15-19 2005, Montreal, Quebec.

  38. Boostanfar R, Ivakhnenko V, Le A, Feinman M, Behr B, Potter D. MicroSort and P.G.D.: Separating the Boys from the Girls. Presented at the 54th Annual meeting of the Pacific Coast Reproductive Society, April 26-30, 2006, Indian Wells, California.

  39. Le A, Boostanfar R, Feinman M, Wang H, Behr B. Comparison of Ultrasound Guided and Traditional Blind Embryo Transfer on Pregnancy Rate Outcome. Presented at the 54th Annual meeting of the Pacific Coast Reproductive Society, April 26-30, 2006, Indian Wells, California.

  40. Boostanfar R, Tourgeman D, Feinman M. Patient Friendly IVF- A Gonadotropin Stimulation Protocol of 10 Injections Total. Presented at the 55th Annual meeting of the Pacific Coast Reproductive Society, April 18-22, 2007, Rancho Mirage, California.

  41. Boostanfar R, Koper N.P, Devroey P, Fauser B.C, Ijzerman-Boon P.C, Mannaerts B, Corifollitropin Alfa Demonstrates Similar Pregnancy Rates As Compared To Daily Recombinant FSH Treatment In A Controlled Ovarian Stimulation Regimen For IVF/ICSI, Presented at the 2008 American Society of Reproductive Medicine , November 8-12, 2008, San Francisco, California.

  42. Boostanfar R, Witjes, Mannaerts B, Gordon K, Mahony M, Clinical Outcomes with a Fixed rFSH/GnRH Antagonist Protocol in a Large North American Cohort of IVF/ICSI Patients. Presented at the 58th Annual meeting of the Pacific Coast Reproductive Society, April 16-20, 2010, Indian Wells, California.

  9

  43. Boostanfar R, Devroey P, Oberye J, Mannaerts B, No Difference in the Cummulative Pregnancy Rates or Live Birth Rates When Comparing Corifollitropin Alfa With Daily rFSH Treatment for COS. Presented at the 26th Annual meeting of the European Society of Human Reproduction and Embryology, June 27-30, 2010 Rome, Italy.

  44. Boostanfar R, Mannaerts B, Witjes H, Devroey P, International Differences in IVF Live Birth Rates and Cumulative Ongoing Pregnancy Rates Following Ovarian Stimulation with Corifollitropin Alfa or Recombinant FSH. Presented at the 2011 American Society of Reproductive Medicine, October 15-19, 2011, Orlando, Florida.


美国试管微信号:1102673035
回复

使用道具 举报

您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

关注0

粉丝3

帖子155

发布主题
一周热帖排行最近7x24小时热帖
欧路尔客服热线

15801391788

服务时间:工作日6:00-24:00
北京南四环西路128号诺德中心
邮箱:378691840@qq.com
  • 官方微信→

  • 在线咨询→

声明:本网站所有内容均出于传递更多信息之目的并,不意味着赞同其观点或证实其描述.本站不承担由此引起的法律责任.

北京欧路尔科技有限公司 ( 京ICP备2021003421号-5 ) www.oluer.com